Studied groups | t/x2 | p-value | ||
---|---|---|---|---|
Magnesium sulfate group (n = 25) | Labetalol group (n = 25) | |||
Age(years) | 31.8 ± 5.6 | 32.9 ± 5.7 | t = 0.67 | 0.50 |
Sex | ||||
male | 14 (56%) | 13 (52%) | x2 = 0.08 | 0.77 |
female | 11 (44%) | 12 (48%) | ||
ASA | ||||
I | 13 (52%) | 14 (56%) | x2 = 0.08 | 0.77 |
II | 12 (48%) | 11 (44%) | ||
BMI (kg/m2) | 25.5 ± 2.6 | 25.2 ± 2.7 | t = 0 .35 | 0.72 |
Duration of surgery ( min) | 104.2 ± 7.1 | 104.1 ± 5.5 | t = 0.09 | 0.93 |
Type of surgery | ||||
• Endoscopic septoplasty | 4 (16%) | 5 (20%) | x2 = 0.36 | 1 |
• FESS | 10(40%) | 1144%) | ||
• Rhinoplasty | 6 (24%) | a.(20%) | ||
• Septoturbanoplasty | 5 (20%) | 4 (16%) |